Olfactory suppression
Olfactory suppression (hyposmia or anosmia) is the diminishment or complete loss of smell perception, rendering previously noticeable odors faint, indistinct, or entirely undetectable.
Description
Olfactory suppression refers to a dose-dependent reduction in the ability to perceive smells, ranging from mild dulling of olfactory sensitivity to a near-complete loss known clinically as anosmia. During this state, the rich landscape of ambient scent that normally pervades everyday experience fades into a flat, odorless background. Foods lose much of their aromatic complexity, environmental smells become undetectable, and the subtle olfactory cues that normally inform our perception of the world — the freshness of air, the proximity of other people, the character of a room — simply disappear.
The experience is notable for how rarely people consciously notice it in the moment. Unlike visual or auditory suppression, which are immediately obvious because we rely so heavily on those senses, olfactory suppression tends to occur quietly. Most people don't actively monitor their sense of smell, so its diminishment often goes unremarked until they try to smell something intentionally — food, a candle, another person — and discover that the signal simply isn't there. This makes olfactory suppression one of the more "invisible" subjective effects, frequently overshadowed by more dramatic changes in consciousness.
The mechanism involves decreased sensitivity at the olfactory receptor level combined with central nervous system depression that reduces the brain's processing of olfactory input. Dissociatives achieve this through broad sensory suppression — the same NMDA receptor antagonism that produces analgesia, tactile suppression, and emotional numbing also dampens olfactory processing. Opioids and other depressants similarly reduce sensory acuity as part of their general sedative profile.
Olfactory suppression is most commonly associated with dissociatives — ketamine, PCP, DXM, and their analogs produce it reliably at moderate doses. It also occurs withdepressants including opioids, antipsychotics, and heavy doses of benzodiazepines. It typically co-occurs with other forms of sensory suppression (tactile, gustatory) as part of a general dampening of sensory experience. While rarely a primary concern, it can contribute to the overall sense of disconnection from the physical world that characterizes dissociative states.